Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots

Biomaterials

Volumn 33, Issue 12, 2012, Pages 3494-3501

  Muthu, Madaswamy S ^a,b   Kulkarni, Sneha A ^a   Raju, Anandhkumar ^a   Feng, Si Shen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Cancer nanotechnology; Molecular biomaterials; Nanomedicine; Quantum dots; Stealth liposomes; Theranostic approach

Indexed keywords

CANCER NANOTECHNOLOGY; NANOMEDICINES; QUANTUM DOT; STEALTH LIPOSOMES; THERANOSTIC APPROACH;

BIOLOGICAL MATERIALS; CELL CULTURE; CONFOCAL MICROSCOPY; DRUG PRODUCTS; MEDICAL IMAGING; MEDICAL NANOTECHNOLOGY; PHOSPHOLIPIDS; POLYDISPERSITY; POLYETHYLENE GLYCOLS; SEMICONDUCTOR QUANTUM DOTS; SURFACE CHEMISTRY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

LIPOSOMES;

DOCETAXEL; FOLATE RECEPTOR; LIPOSOME; QUANTUM DOT; SOLVENT; TOCOFERSOLAN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER THERAPY; CELL CULTURE; CELL STRAIN MCF 7; CONFOCAL LASER MICROSCOPY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; FIELD EMISSION; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; HYDROPHOBICITY; IC 50; IN VITRO STUDY; PARTICLE SIZE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; ZETA POTENTIAL;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; HUMANS; LIPOSOMES; POLYETHYLENE GLYCOLS; QUANTUM DOTS; RADIATION-SENSITIZING AGENTS; TAXOIDS; VITAMIN E;

EID: 84857061382     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.01.036     Document Type: Article

References (36)

1. Huang C. Studies on phosphatidylcholine vesicles, formation and physical characteristics. Biochemistry 1969, 8:344-352.
2. Muthu M.S., Feng S.S. Nanopharmacology of liposomes developed for cancer therapy. Nanomedicine 2010, 5:1017-1019.
3. Samad A., Sultana Y., Aqil M. Liposomal drug delivery systems: an update review. Curr Drug Deliv 2007, 4:297-305.
4. Elbayoumi T.A., Torchilin V.P. Current trends in liposome research. Methods Mol Biol 2010, 605:1-27.
5. Helfrich W. The size of bilayer vesicles generated by sonication. Phys Lett A 1974, 50:115-116.
6. Lasic D.D., Papahadjopoulos D. Medical application of liposomes 1998, Elsevier, Amsterdam, The Netherlands.
7. Feng S.S., Ruan G., Li Q.T. Fabrication and characterizations of a novel drug delivery device liposomes-in-microsphere (LIM). Biomaterials 2004, 25:5181-5189.
8. Bawarski W.E., Chidlowsky E., Bharali D.J., Mousa S.A. Emerging nanopharmaceuticals. Nanomedicine 2008, 4:273-282.
9. Wu S.H.W., Hopkins W.K. Characteristics of D-α-tocopheryl polyethylene glycol 1000 succinate for applications as an absorption enhancer in drug delivery system. Pharm Technol 1999, 23:52-68.
10. Varma M.V.S., Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci 2005, 25:445-453.
11. Boudreaux J.P., Hayes D.H., Mizrahi P., Maggiore P., Blazek J., Dick D. Use of water-soluble liquid vitamin E to enhance cyclosporine absorption in children after liver transplant. Transplant Proc 1993, 25:1875.
12. Chang T., Benet L.Z., Hebert M.F. The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 1996, 59:297-303.
13. Dintaman J.M., Silverman J.A. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999, 16:1550-1556.
14. Mu L., Elbayoumi T.A., Torchilin V.P. Mixed micelles made of poly(ethylene glycol) phosphatidylethanolamine conjugate and D-α-tochopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarrier for campotothecin. Int J Pharm 2005, 306:142-149.
15. Mu L., Feng S.S. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharm Res 2003, 20:1864-1872.
16. Zhang Z.P., Feng S.S. The drug encapsulation efficiency, in vitro release, cellular uptake and cytotoxicity in paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 2006, 27:4025-4033.
17. ®). J Control Release 2002, 80:129-144.
18. Feng S.S. New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?. Nanomedicine 2006, 1:297-309.
19. Khin Y.W., Feng S.S. In vitro and in vivo studies on vitamin E TPGS-emulsified poly (D, L-lactic-co-glycolic acid) nanoparticles for clinical administration of paclitaxel. Biomaterials 2006, 27:2285-2291.
20. Muthu M.S., Kulkarni S.A., Xiong J., Feng S.S. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm 2011, 421:332-340.
21. Wang AJ, Wang PL, Lu SJ. Long circulating liposome. US Patent No: 0142182, 2005.
22. Parmentier J., Hartmann F.J., Fricker G. In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules. Eur J Pharm Biopharm 2010, 76:394-403.
23. Parmentier J., Becker M.M., Hartmann F.J., Fricker G. Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids. Int J Pharm 2011, 405:210-217.
24. Muthu M.S., Singh S. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine 2009, 4:105-118.
25. Muthu M.S., Rajesh C.V., Mishra A., Singh S. Stimulus responsive targeted nanomicelles for effective cancer therapy. Nanomedicine 2009, 4:657-667.
26. Sigot V., Arndt-Jovin D.J., Jovin T.M. Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes. Bioconjug Chem 2010, 21:1465-1472.
27. Pan J., Liu Y., Feng S.S. Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment. Nanomedicine 2010, 5:347-360.
28. Yang C., Ding N., Xu Y., Qu X., Zhang J., Zhao C., et al. Folate receptor-targeted quantum dot liposomes as florescence probes. J Drug Target 2009, 17:502-511.
29. Lee R.J., Low P.S. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1995, 1233:134-144.
30. Yuan Z., Chen D., Zhang S., Zheng Z. Preparation, characterization and evaluation of docetaxel-loaded folate-conjugated PEG-liposomes. Yakugaku Zasshi 2010, 130:1353-1359.
31. Muthu M.S., Rawat M.K., Mishra A., Singh S. PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. Nanomedicine 2009, 5:323-333.
32. Muthu M.S., Singh S. Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation. Nanomedicine 2008, 3:305-319.
33. Carafa M., Marianecci C., Di Marzio L., De Caro V., Giandalia G., Giannola L.I., et al. Potential dopamine prodrug-loaded liposomes: preparation, characterization, and in vitro stability studies. J Liposome Res 2010, 20:250-257.
34. Gan C.W., Feng S.S. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Biomaterials 2010, 31:7748-7757.
35. Wu J., Liu Q., Lee R.J. A folate receptor-targeted liposomal formulation for paclitaxel. Int J Pharm 2006, 316:148-153.
36. Mi Y., Liu Y., Feng S.S. Formulation of docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. Biomaterials 2011, 32:4058-4066.